JAM3
JAM3, also known as JAM-C, JAMC or JAM-3, is an immunoglobulin superfamily member of the junctional adhesion molecule family. It localises to tight junctions between high endothelial cells and promotes chemotaxis of vascular endothelial cells and angiogenesis. Browse Assay Genie's current range of JAM3 research reagents below, or read on for the biology behind the target.
Tight junctions are one mode of cell-to-cell adhesion in epithelial and endothelial cell sheets. They form continuous seals around cells and act as a physical barrier that stops solutes and water passing freely through the paracellular space. JAM3 (junctional adhesion molecule 3) is localised in the tight junctions between high endothelial cells. Functionally, it promotes chemotaxis of vascular endothelial cells and stimulates angiogenesis.
The JAM3 protein belongs to the immunoglobulin superfamily and to the junctional adhesion molecule family, and it acts as a receptor for another member of this family. Unlike other proteins in the family, it cannot adhere to leukocyte cell lines and forms only weak homotypic interactions. UniProt records it at the cell membrane, at cell junctions including tight junctions and desmosomes, and as a secreted form. Alternative splicing of the JAM3 gene produces multiple transcript variants. HGNC places the gene in the V-set domain containing and Ig-like cell adhesion molecule groups. Mouse and rat both have a Jam3 ortholog.
The protein is also called junctional adhesion molecule C, JAM-C, JAMC and JAM-3. On disease relevance, a mutation in an intron of the JAM3 gene has been associated with hemorrhagic destruction of the brain, subependymal calcification and congenital cataracts. Researchers studying endothelial barrier biology, vascular development and junctional signalling use JAM3 antibody, JAM3 ELISA kit and JAM3 protein reagents to investigate these processes.
JAM3 sits in tight junctions between high endothelial cells, which seal cell sheets and restrict paracellular passage of solutes and water.
JAM3 stimulates angiogenesis and promotes chemotaxis of vascular endothelial cells, making it relevant to studies of new vessel formation.
JAM3 forms only weak homotypic interactions and does not adhere to leukocyte cell lines, which sets it apart within its family.
An intronic JAM3 mutation is linked to brain haemorrhagic destruction, subependymal calcification and congenital cataracts.
JAM3 is a tight junction protein found between high endothelial cells. It promotes chemotaxis of vascular endothelial cells and stimulates angiogenesis. It also acts as a receptor for another junctional adhesion molecule family member, and it forms only weak homotypic interactions.
JAM3 is the HGNC symbol for junctional adhesion molecule 3. UniProt names the protein junctional adhesion molecule C, and aliases include JAM-C, JAMC and JAM-3. Alternative splicing of the gene gives multiple transcript variants.
A mutation in an intron of the JAM3 gene is associated with hemorrhagic destruction of the brain, subependymal calcification and congenital cataracts. Mouse and rat each have a Jam3 ortholog; check the datasheet of any product for its validated reactivity.
Other junctional adhesion molecules and related cell adhesion targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BX67; product specifications from Assay Genie datasheets.